The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

Patients with uveitis had a higher risk for psoriatic arthritis and psoriasis, whereas those with psoriatic arthritis had a higher risk for uveitis.

Higher adherence to the MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet in mid to late life is associated with a reduced risk for Alzheimer disease and related dementias (ADRD) ...

Mortality and rates of respiratory hospitalization were similar among patients with RA-ILD initiating various non-TNF inhibitor b/tsDMARDs.

Supplementation with vitamin D3 is associated with reduced telomere attrition in adults aged 50 years and older.

A multidisciplinary approach involving both pulmonologists and rheumatologists may lead to earlier ILD diagnosis among patients with SARDs.

Depression across the life course is associated with an increased risk for dementia, according to a study published online.

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Which of the statements about the updated EULAR recommendations for antirheumatic drug use in reproduction, pregnancy, and ...

Individuals with RA are significantly more likely to develop sleep disorders, particularly insomnia, compared with the general population.

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

Janus kinase (JAK) inhibitors are not associated with an increased risk for gastrointestinal perforation (GIP) among patients with rheumatoid arthritis (RA), according to study results published in ...